Jonathan Webster

16 posts

Jonathan Webster

@LeukDocWebster

Assistant Professor of Oncology, Division of Hematologic Malignancies, Leukemia Group, Johns Hopkins University

Baltimore, MD Katılım Kasım 2021

118 Takip Edilen170 Takipçiler

Jonathan Webster retweetledi

Johns Hopkins Hematology and Oncology Fellowship@Hopkins_HemOnc·1 Haz

Congratulations to our fellows (@SaumyaMaruMDPhD, Neha Verma, @mnakazawa7, Nazila Shafagati, Daniel Shu, @michaelconroy, Jesse Handler) on their @ConquerCancerFd #ASCOYIA awards and former fellow and current @hopkinskimmel Asst. Prof. Eric Christenson for the #ASCOCDA!

Johns Hopkins Hematology and Oncology Fellowship tweet media

English

2.1K

Jonathan Webster retweetledi

Kristina Montemayor@KMonty_MD·16 Kas

Congratulations @ANiranjanAzadi #OslerPride

Hopkins Hospital Medicine@HopkinsHospMed

Congratulations to one of our great Hospitalists @ANiranjanAzadi who was just named Physician of the Year for the @SocietyHospMed MD Chapter!

English

1.7K

Jonathan Webster retweetledi

Javier Bolaños Meade, MD@GvHD_Meade·22 Haz

An incredible amount of work with really brilliant people made #BMTCTN1703 a success and the new SOC for #GvHD prophylaxis #PTCyRules #BMTCTN @CIBMTR Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM nejm.org/doi/full/10.10…

English

230

50.2K

Jonathan Webster retweetledi

Johns Hopkins Hematology and Oncology Fellowship@Hopkins_HemOnc·9 Haz

Congratulations to the graduating class of 2023! We are so proud of you, we love you, and we will miss you. You are all going to do great things!

English

4.2K

Jonathan Webster@LeukDocWebster·30 May

Sending @cappelliMD off to Milan for #EULAR2023 #aleagueoftheirown

English

1.3K

Jonathan Webster@LeukDocWebster·21 May

Great article from @NicholasShortMD and colleagues with important implications for MRD monitoring in Ph+ ALL and our understanding of the fundamental biology underlying Ph+ ALL vs de novo lymphoid blast crisis of CML vs ?Ph+ ALL with CML-like biology.

Nicholas Short MD@NicholasShortMD

👉👉Our new paper in @AjHematology on #MRD in Ph+ #ALL. High rates of discordance between NGS for IG/TR and PCR for BCR::ABL1. High sensitivity NGS MRD may be superior to PCR and identifies PCR+ pts with low risk of relapse. Important implications for MRD monitoring in Ph+ ALL.

English

1.4K

Jonathan Webster retweetledi

Keith W Pratz MD@PratzKW·13 Ara

#ASH2022 Late breaking abstract on frontline Blinatumomab in adult ALL E1910. Amazing results and new SOC. Congratulations Mark Litzow and study team.

English

Jonathan Webster retweetledi

Keith W Pratz MD@PratzKW·11 Ara

⁦@DrChrisHourigan⁩ presenting words of wisdom from our great mentor Judy Karp at the #ASH22 AML education session.

English

Jonathan Webster retweetledi

Rakhi Naik, MD MHS@redcell_doc·3 Kas

Embargo lifted! Congratulations to our @HopkinsHeme trainees who were awarded ASH Abstract Achievement Awards!! 🌟Michael Hochman @mjhochman, Chief Heme Fellow @Hopkins_HemOnc 🌟Macy Early @macy_early, ASH Med Student PS Awardee 🌟 Jayla Scott, Hopkins Woodrow Wilson Awardee 🧵

English

Jonathan Webster retweetledi

Johns Hopkins Thoracic Oncology@HopkinsThoracic·28 Eyl

Congratulations to Dr. @kamarroneMD on receipt of a multi-year career development award from @LUNGevity to study neoadjuvant immunotherapy and targeted therapy for surgical lung cancer harboring a #kras mutation! lungevity.org/news/media-rel…

Johns Hopkins Thoracic Oncology tweet media

English

105

Jonathan Webster@LeukDocWebster·20 Ağu

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia nature.com/articles/s4137…

English

Jonathan Webster retweetledi

Keith W Pratz MD@PratzKW·8 Tem

We are happy to share @DrAndyMatthews work on: Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Thx @SelinaLugerMD @ParalkarLab and UPenn leukemia team doi.org/10.1182/blooda…

English

Jonathan Webster retweetledi

Chris Hourigan@DrChrisHourigan·2 Haz

Live action footage of Houriganlab.com arrival at #ASCO2022 Huge AML MRD dataset to present on Tuesday - but also the hoping to use this time away to write the paper...